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Recent demand for increased understanding of avian 
infl uenza virus in its natural hosts, together with the devel-
opment of high-throughput diagnostics, has heralded a new 
era in wildlife disease surveillance. However, survey design, 
sampling, and interpretation in the context of host popula-
tions still present major challenges. We critically reviewed 
current surveillance to distill a series of considerations per-
tinent to avian infl uenza virus surveillance in wild birds, in-
cluding consideration of what, when, where, and how many 
to sample in the context of survey objectives. Recognizing 
that wildlife disease surveillance is logistically and fi nancially 
constrained, we discuss pragmatic alternatives for achiev-
ing probability-based sampling schemes that capture this 
host–pathogen system. We recommend hypothesis-driven 
surveillance through standardized, local surveys that are, in 
turn, strategically compiled over broad geographic areas. 
Rethinking the use of existing surveillance infrastructure 
can thereby greatly enhance our global understanding of 
avian infl uenza and other zoonotic diseases. 
Avian infl uenza virus (AIV) gained a high profi le af-ter the unprecedented bird-to-human transmission of 
highly pathogenic AIV (HPAIV) subtype H5N1 in 1997. 
Originating in Asia, HPAIV (H5N1) subsequently caused 
widespread deaths among wild and domestic birds in South-
east Asia and westward throughout Europe and Africa in 
2005 and 2006. After ≈50 years of research in wild birds, 
a wide range of low-pathogenicity AIV (LPAIV) subtypes 
is known to circulate in numerous species (1,2–5), and 
LPAIVs are believed to perpetuate in aquatic bird popula-
tions (6). In contrast, outbreaks of HPAIV are extremely 
rare in wild birds (7). Although the role of wild birds in 
HPAIV maintenance remains controversial (8), the mag-
nitude of the subtype H5N1 epidemics increased the de-
mand for early recognition of potential threats to humans 
and poultry and an understanding of the natural history of 
AIV in wild birds. Consequently, surveillance of aquatic 
bird populations surged (9).
Although surveillance for AIV often uses state-of-
the-art storage, transport and diagnostics, these must be 
underpinned by appropriate survey design, sampling, and 
interpretation in the context of the host population. In the 
wake of such rapid growth in surveillance, we reviewed 
the literature to determine a scientifi cally and statistically 
sound approach to the design, conduct, and interpretation 
of surveillance for AIV and other wildlife diseases.
Current Surveillance
We reviewed 191 published reports of surveillance in 
wild birds (online Technical Appendix, http://www.cdc.
gov/EID/content/16/12/1827-Techapp.pdf). The number 
of studies initiated per year rapidly increased after the fi rst 
reports of HPAIV (H5N1) in Asia (Figure 1). All studies 
addressed 4 major lines of investigation: 1) early detection 
of HPAIVs; 2) ecology and epidemiology of LPAIV in 
host populations; 3) diversity and evolution of viral strains 
within wild birds; and 4) identifi cation of the pathogens 
that infect individual birds or populations, often as part of 
multipathogen surveillance. Multiple aims can, and often 
are, addressed within the same surveillance program, al-
beit in a post hoc manner. However, identifying the aims in 
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advance is vital, because what, when, and where to sample 
will critically depend on the purpose of the survey (10,11).
Early Detection of HPAIV
More than half of the studies reviewed, and all but a 
handful initiated since the mass bird deaths in 2005–2006, 
cited early detection of HPAIV as one of the main goals 
of conducting the research (Figure 1). Such early warning 
systems question whether HPAIV exists in a population 
at a given location and point in time. The global rarity of 
HPAIV in wild birds and apparent clustering of such cases 
(7) present additional challenges to addressing this aim.
Ecology and Epidemiology
Greater understanding of transmission cycles, res-
ervoirs, and the role of wildlife in the dynamics of AIV 
invoke questions related to the epidemiology and ecology 
of the virus, including host range and spatial and temporal 
variation in infection (12,13). Elucidating such questions 
requires investigating not just presence or absence of infec-
tion in a specifi c host, but also prevalence over space and 
time.
Viral Diversity
Infl uenza viruses are highly diverse and capable of 
rapid genetic alteration. Understanding the pathogenic and 
antigenic properties of AIVs circulating in the host popula-
tion and the rate and direction of genetic alterations could 
become a powerful tool for identifying transmission pa-
rameters, reservoir populations (14), viral maintenance in 
the face of host immunity (12,15), and factors promoting 
disease emergence (10). Such information also facilitates 
compilation of comprehensive diagnostic reference panels 
and generation of potential vaccines (13). Investigation of 
variation in the viral population requires isolates that repre-
sent the entire circulating virus pool.
Host Health
Almost 15% of the studies reviewed aimed to ascertain 
whether certain individuals or populations had been infect-
ed with AIV as part of broader health surveys within the 
context of conservation programs, or in an attempt to un-
derstand causes of death. Although these studies often have 
a predefi ned host population of interest, they are likely to 
be sensitive to the underlying spatial and temporal patterns 
of disease.
Critical Assessment
To characterize the specifi c features required for rigor-
ous wildlife disease surveillance, it is critical to highlight 
methods that encumber our current approach. Our assess-
ment therefore aims to foster the development of more 
objective and scientifi cally sound disease surveillance net-
works.
Maximizing Viral Yield
A successful surveillance program is often perceived 
as one that identifi es a high number of positive samples. 
Moreover, exploitation of spatial, temporal, phylogenetic, 
and demographic differences in viral prevalence have been 
advocated to maximize the proportion of positive samples 
collected (12,16). Minimizing the number of negative sam-
ples is expedient from a laboratory perspective, particularly 
when labor-intensive virus isolation techniques are being 
used. However, a key tenet of surveillance is that the sam-
pling scheme is representative: infection characteristics of 
the host population and genetic diversity of the viral popula-
tion are suffi ciently captured, and results can be interpreted 
on the basis of statistical probability (11,17). A study de-
signed to maximize the number of positive samples by sam-
pling historically high cohorts, populations, times, and loca-
tions can confi rm the presence of the disease in the sampled 
cohort. However, such samples cannot be used to conclude 
the absence of AIV in the population or to estimate preva-
lence or diversity of circulating viral strains (17).
Host Range
Although AIVs have been isolated from >100 species, 
several species from the orders Anseriformes (ducks, geese, 
and swans) and Charadriiformes (shorebirds) are thought to 
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Figure 1. Average number of surveys of avian infl uenza in wild birds 
initiated per year in different awareness periods: each decade from 
the fi rst discovery in 1961 until the outbreak of highly pathogenic 
avian infl uenza virus (HPAIV) (H5N1) in Asia in 1997; the period 
after the fi rst outbreak, 1997–2004; and the period after mass deaths 
of wild birds from HPAIV (H5N1) (2005–2007). Black bar sections 
indicate studies citing the detection of contemporary HPAIV strains 
as one of the main aims of their survey are indicated in black; white 
bar sections indicate studies investigating other aspects of the wild 
bird–avian infl uenza system without mention of monitoring HPAIV.
Surveillance of Wild Birds for Avian Infl uenza Virus 
act as the reservoir community for AIV (6), primarily be-
cause AIVs have been most frequently isolated from these 
groups (9). Yet, surveillance is rarely representative of the 
diversity of wild birds or their relative abundance at the 
time and location of sampling. Considerable bias exists to-
ward species that are easily caught or are present in acces-
sible areas at high concentrations (9,13). Surveys that have 
included a wide range of species often obtained samples in 
a highly opportunistic manner, resulting in few species be-
ing sampled in reasonable numbers (12,13). For instance, 
despite sampling >56,000 birds in the Netherlands from 
1998 to 2009, only 20 of the 174 species were sampled 
>300 times. Moreover, prevalence in a given species may 
vary over space and time. Although passerines have often 
been found negative for AIV, recent evidence suggests that, 
when sampled in or near waterfowl-rich bodies of water, a 
high proportion of individuals from 8 different passerine 
families show infection (18,19). Current surveillance may, 
therefore, overlook many potential reservoir or transient 
host species and their role in the introduction, transmission, 
maintenance and diversity of AIV.
Temporal and Spatial Patterns
The prevalence of AIV infection has long been recog-
nized to vary over time and space. Viruses have been most 
frequently isolated from duck populations in North Ameri-
ca and Europe in late summer and early autumn (5,15,20), 
a pattern attributed to high concentrations of susceptible 
juvenile birds on premigratory staging grounds (4,6). 
Less frequent isolations from wintering populations have 
prompted suggestions that prevalence rapidly decreases 
over the course of autumn migration (21,22); thus, premi-
gratory staging grounds in late summer and early autumn 
are considered the optimal time and location for conducting 
surveillance among waterfowl (16,23). Yet when samples 
have been collected elsewhere, high numbers of AIVs have 
been isolated in winter (21,24), spring (20), and summer 
(25). Several positive samples from birds in the tropics (26) 
have also been found, including unexpectedly high num-
bers in tropical Africa (27). The temporal and spatial bias 
in existing surveillance may therefore result in delayed de-
tection of novel strains or an incomplete understanding of 
AIV transmission, maintenance, diversity, and evolution.
Age-dependent Patterns
Pioneering work by Hinshaw et al. (4) found signifi -
cantly higher prevalence of AIV infection among juvenile 
birds than among contemporaneously sampled adult birds, 
leading to the suggestion that immunological naivety may 
make juvenile birds a high-risk group within waterfowl 
populations. Emphasis has subsequently been placed on 
sampling juvenile birds; accounting for ≈80% in some re-
cent surveys. However, wild bird populations are rarely 
composed of >80% juvenile birds, and numerous infected 
adults have also been found (4,24). Given that recent ex-
perimental results indicate that age at the time of infection 
might also affect the extent of viral shedding (28), differ-
ent age cohorts may play different roles in the introduction, 
transmission, maintenance, and diversity of AIVs.
Site of Infection
AIVs replicate in the gastrointestinal tract (sampled 
by swabbing the cloaca or collecting droppings) and in 
the respiratory tract (sampled by swabbing the orophar-
ynx) (16). Individual mallards (Anas platyrhynchos) have 
historically shown higher detection probability from cloa-
cal c.f. oropharyngeal swabs (29; Figure 2). Accordingly, 
61% of studies investigating contemporary infection sam-
pled the gastrointestinal tract alone. However, the site of 
infection may differ between species. As part of ongoing 
surveillance (21,29), free-living Eurasian wigeons (Anas 
penelope) showed no difference in detection probability 
between the cloacal and oropharyngeal swabs (p>0.05, 
McNemar test; Figure 2). In contrast, white-fronted geese 
(Anser albifrons) were roughly 2× as likely to have infec-
tion detected in the oropharynx (6.58%; 95% confi dence 
interval 6.57–6.59) than in the cloaca (3.13%; 95% confi -
dence interval 3.13–3.14; p <0.001); ≈60% of the infected 
birds were positive by oropharynx sample alone (Figure 2). 
Together with the apparent oropharynx affi nity of HPAIV 
(H5N1) in experimental and natural infections (30), these 
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 16, No. 12, December 2010 1829 
Figure 2. Proportion of wild mallards (Anas platyrhynchos), 
Eurasian wigeons (Anas penelope), and white-fronted geese (Anser 
albifrons) positive for low-pathogenicity avian infl uenza virus when 
sampled in the cloaca (C) and the oropharynx (O), the Netherlands, 
September 2006–March 2009.
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fi ndings have ramifi cations for the quantifi cation of viral 
diversity, prevalence of infection, or absence of AIV.
Disease-free Populations and Prevalence Estimates
In general, survey sample sizes must be suffi ciently 
large to draw appropriate inferences, and interpretations of 
AIV in wild birds based on many current sampling schemes 
may be hampered due to the limited number of samples 
collected (9). Studies have often concluded that AIV, par-
ticularly HPAIV (H5N1), was absent from a certain pop-
ulation or location. Infected birds may indeed have been 
present, but at a prevalence below the level of detection of 
the study (17). Only 3 of the studies that reported negative 
fi ndings acknowledged a detection limit, yet such informa-
tion is crucial to screening for HPAIV incursion. Similarly, 
81 (42%) of the articles reviewed explicitly reported preva-
lence or seroprevalence; however, just 3 of these accounted 
for the uncertainty of their estimates (i.e., confi dence lim-
its). Such reports have fostered an impression that preva-
lence is a fi xed property of a given host population, rather 
than a dynamic quantity, potentially infl uenced by many 
temporal, geographic, and biological interactions.
Utility of Birds Found Dead
Many surveillance programs aimed at the early detec-
tion of HPAIV (H5N1) focus on collections from sick or 
dead birds, often without surveillance of the living avian 
population (31). Although fi nding an HPAIV (H5N1) in-
fection is statistically more likely in birds found dead (31), 
the absence of dead birds (or infection in dead birds) does 
not indicate freedom from disease. Dead birds fail to pro-
vide information on any animals that survived the infec-
tion, any animals that were not infected, or any viruses that 
were not lethal (30). Moreover, large numbers of carcasses 
may go undetected or unreported (10).
Screening for Only the Current Strain of Interest
Recently, some studies have only screened for H5 
strains. Yet, none of the known genotypes can be ruled out 
as potential candidates for future pandemics. Additional in-
formation on all circulating gene segments is preferable as a 
novel-incursion warning system and in the broader context 
of AIV ecology, epidemiology, and evolution, particularly 
because no additional sample collection is necessary.
A Way Forward?
Although ≈50 years have passed since AIVs were 
fi rst detected in wild birds, research is still in the explor-
atory phase, primarily because sampling wild animals is 
logistically challenging and expensive and techniques for 
high-throughput molecular surveillance have only recently 
become available. Wildlife disease surveillance regularly 
involves limited samples obtained in various ways that are 
already readily available, such as ornithologist-captured 
and hunter-collected birds. Although these methods of con-
venience sampling are often assumed to be representative 
of a population, sampling biases (most notably selection 
bias) do occur, making it diffi cult to develop statistically 
valid estimates of disease absence or prevalence, regardless 
of how many birds are sampled.
Our critique illustrates that to build on the fi ndings of 
existing surveillance a scientifi cally sound approach is re-
quired. A study’s aims need to be clearly identifi ed at the 
outset, and appropriately designed sampling regimes and 
diagnostic techniques must be used. The global distribution 
of AIV and its avian hosts presents a major hurdle for such 
hypothesis-based research, making it diffi cult for individual 
research groups to tackle these questions in isolation. Our 
review highlights the need for global collation of existing 
wild bird AIV data and infrastructure, as well as the pool-
ing of expertise and resources between epidemiologists, 
ornithologists, geneticists, and conservation organizations 
to unravel the complex interactions among diverse host 
and viral populations and the environments they utilize. 
Many such international initiatives exist in principle; how-
ever, there are currently several challenges in terms of data 
coverage, compatibility, management, and ownership. The 
following section outlines key considerations pertaining to 
the design, implementation, and interpretation of local sur-
veys that could ameliorate data coverage and compatibility 
problems, paving the way for increasingly integrated stud-
ies of AIV and other wildlife diseases.
Sampling Unit
Target Virus
Particular strains, especially those with a history of 
HPAIV potential (H5 and H7), are of greatest interest when 
screening for HPAIV (16). However, screening for other 
virus subtypes by virus isolation, or targeting the matrix 
gene segment in molecular-based diagnostics, will simul-
taneously enhance our ecologic, epidemiologic, and viro-
logic understanding of AIV.
Dead or Alive
Birds found dead may indicate rapid changes in host 
range, geographic range, viral pathogenicity, or disease 
emergence, and as such warrant swift investigation. How-
ever, to clarify the presence or absence of HPAIV, as well 
as trends in LPAIV presence, prevalence, and circulating 
strains, such surveys should be paired with active surveil-
lance of the living wild bird population.
Sampling Site within the Bird
Viral strains of different host origin may differ in their 
affi nity for either the digestive or respiratory tract and may 
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also differ between different host species. Sampling the 
cloaca/feces and oropharynx is therefore desirable when 
screening wild birds. Such differences also exemplify the 
need for experimental clarifi cation of tract affi nity and how 
this may infl uence interpretations based on a single sample 
type (e.g., droppings).
Which Populations Should Be Sampled?
Target Population
With >10,000 species of birds worldwide, careful se-
lection of a local target population is critical to the design 
of any surveillance program. Because the prevalence of 
infection is generally low (requiring large sample sizes) 
and can vary over time and between locations within a spe-
cies, it is diffi cult to make an initial assessment of the most 
important species to target on the basis of virus detection 
alone. Each of the surveillance aims outlined above may 
be most appropriately addressed by considering 1) popula-
tions with evidence of previous infection, or ecologic po-
tential for infection (32), on the basis of not only existing 
literature and conventional monitoring but also serosurveil-
lance in a large number of locally and regionally abundant 
species; and 2) Evidence of contemporary AIV infection 
in populations that were identifi ed in step 1, and species 
in which AIV has historically been detected (for compara-
tive purposes). Surveillance for emergent HPAIV may also 
benefi t from targeting species displaying natural histories 
of interest, including species that link wild and human/ag-
ricultural populations or disparate locations.
Serologic studies have great potential for enhancing 
wildlife disease surveillance and understanding. However, 
in isolation, cross-sectional observations of seroprevalence 
provide insuffi cient information to interpret the degree to 
which a population has been infected with AIV. Without 
age specifi city, high seroprevalence may indicate a recent 
outbreak of infection or long-term antibody maintenance 
rather than persistence of AIV infection in the population 
(14,16). Moreover, low seroprevalence may result from a 
high mortality rate among infected birds, a long time in-
terval between infection and sampling, or species-specifi c 
differences in the sensitivity or specifi city of the antibody 
diagnostics. Explicit interpretation of seroprevalence calls 
for age-specifi c sampling, longitudinal observations, un-
derstanding of the underlying epidemiologic dynamics, and 
experimental validation of antibody diagnostics.
Individual Birds within Populations
Within each species, infection may depend on mul-
tiple factors, including age and prior exposure to AIV (4), 
gender (33), and even nutrition or social status (8). Given 
that most capture methods inherently result in biases within 
these cohorts, a population should ideally be sampled to 
account for these differences. Experimental validation of 
such interindividual differences in infection could greatly 
enhance the design and interpretation of surveillance.
When, Where, and How Often to Sample?
When and where sampling is conducted will critically 
depend on the question at hand and should be representa-
tive of the biology of the hosts of interest. Single time or 
location studies may be suffi cient to inform of novel incur-
sions of HPAIV (Table) and may therefore be best matched 
to times/locations with a high risk for wild bird–poultry in-
teraction. Changes in climatic conditions, host population 
dynamics, and host population immunity are likely relevant 
to understanding the ecology, epidemiology, and evolution 
of AIV in its natural host(s) (34). Enhancing our knowl-
edge in these areas will require information from before, 
during, and after infection from ecologically connected 
populations (35), often over longer periods and across large 
spatial scales when studying migratory birds (36). Coordi-
nated local surveys, both along fl yways and over time, will 
greatly enhance these efforts.
How Many Individual Birds Should Be Sampled?
As prevalence decreases, an increasingly large number 
of birds need to be sampled to detect contemporary infec-
tion (Figures 3, 4). Deciding just how many is critically de-
pendent on the study aim, with a clear distinction between 
surveys that aim to substantiate freedom from infection 
(presence or absence), and those that are designed to pro-
vide an estimate of disease prevalence.
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Table. Data requirements for assessment of major questions regarding avian influenza in wild birds* 
Aim Type of question Geographic range Temporal range Frequency 
Early detection 
of HPAIV 
Presence/absence Local/regional Period when birds present Approximately weekly 
(average infection duration) 
Ecology and 
epidemiology 
Comparative prevalence Local to flyway, depending 
on the process in question 
1 to many epidemic 
seasons (multiple 
times/year) 
Weekly to monthly (multiple 
times before, during, and 
after an epidemic) 
Diversity and 
evolution
Comparative prevalence 
(of viral strains) 
Flyway to global Decades (multiple 
times/year repeated for 
multiple years) 
Monthly to seasonally 
*Larger-scale studies can be compiled over large geographic areas from relevant local surveys that are methodologically comparable and over long 
periods from relevant annual surveys that are likewise methodologically comparable. HPAIV, highly pathogenic avian influenza virus.
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Presence/Absence 
In practice, it is not possible to confi rm disease free-
dom in a large population by any direct observational 
method. Instead, appropriate sampling and analysis can 
demonstrate that at that time and location, prevalence was 
below a nominal detection threshold (online Technical Ap-
pendix) (17). Although this nominal minimum detectable 
prevalence assumes binomial sampling, it can also be used 
for gaining a rough quantitative estimate of the minimum 
number of samples required before embarking on a sur-
veillance program (Figure 3; online Technical Appendix). 
Given that information on the absence of pathogens is cru-
cial to understanding disease dynamics (10), postsurveil-
lance reporting of such maximum undetected prevalence is 
highly desirable for all studies with negative fi ndings. 
Prevalence
The proportion of positive fi ndings among a given 
number of samples is rarely suffi ciently precise to inform 
population prevalence. Thus, the confi dence intervals of 
any observed proportion should be calculated and reported 
alongside any prevalence estimates when reporting surveil-
lance results. Such confi dence limits depend on the number 
of samples taken and the underlying true (unbiased) preva-
lence of infection (Figure 4).
Achieving Effective Surveillance
Each of the points above highlight the need for sur-
veillance that captures the underlying temporal, spatial, 
demographic, and phylogenetic variation in the wild bird 
population, often requiring detailed information on host 
population size, density, demographic structure, rates of 
recruitment and attrition, habitat utilization, and species 
composition. However, wildlife surveillance is also faced 
with substantial logistical and fi nancial constraints. Effec-
tive surveillance, therefore, requires a compromise between 
sampling that is based on probability and the constraints 
of sample collection, transport and analysis, the details of 
which will depend on the specifi c objectives of the survey. 
To this end, it is critical to have active, investigator-defi ned 
surveillance designs based on probability on a larger scale 
while using convenience sampling within these units (11). 
For instance, probability methods could be used to plan the 
species, locations, and months of the year to sample, and a 
certain number of individual birds within these units could 
be sampled by ornithologists and hunters, with additional 
top-up sampling where necessary. Such convenience-with-
in-probability surveillance could provide statistically valid 
estimates of disease absence and prevalence by reducing 
the effect of bias generated by sampling on a fi rst-come-
fi rst-served basis. It facilitates stipulation of an upper limit 
to the use of convenience samples, allowing targeted al-
location of limited sampling, diagnostic, and fi nancial re-
sources.
 To employ such convenience-within-probability sur-
veillance, samples will often need to be collected from 
times, places, and species that are not currently covered 
by ornithologists and hunters. Preferably, individual birds 
should be sampled to confi rm species, gender, age, and 
body mass, and sampling of digestive and respiratory tracts. 
However, when it is logistically and/or fi nancially diffi cult 
to capture live birds several alternatives exist. Swabbing 
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Figure 3. Probability of detecting >1 individual bird infected with 
avian infl uenza virus from a given number of samples selected at 
random from an extremely large population in which individual birds 
are infected at random at different prevalence levels. Although 
this nominal minimum detectable prevalence assumes binomial 
sampling, it can also be used for gaining a rough quantitative 
estimate of the minimum number of samples required before 
embarking on a surveillance program.
Figure 4. The 95% confi dence intervals for prevalence in an 
independent population for a given number of samples, derived 
from the binomial distribution. Confi dence intervals depend on the 
number of samples taken and unbiased prevalence of infection; 
they should be calculated and reported along with prevalence 
estimates when reporting surveillance results.
Surveillance of Wild Birds for Avian Infl uenza Virus 
of fresh, species-specifi c feces is 1 method for collecting a 
regulated number of samples (16). Species should be iden-
tifi ed through careful presampling observation of fl ocks, 
or, when sampling mixed-species fl ocks, through DNA 
barcoding of the fecal samples (37). Given that AIV can be 
detected from the same nucleic acid extract used in species 
identifi cation (37), and substantially more samples can be 
collected at a much higher frequency than traditional trap-
ping methods, dropping samples may greatly enhance our 
capacity to detect AIV in the population. Other, more prox-
imate surveillance methods include sampling surface water 
that is, has been, or is about to be inhabited by wild birds 
(16), as well as regular sampling of sentinel species (38). 
Both methods are likely to yield insight into infection in 
the broader host population (16), although their usefulness 
for understanding infection in specifi c populations must be 
carefully assessed.
Conclusions
Surveillance for wildlife diseases is an inherently ardu-
ous task. However, as the vanguard of our understanding of 
these diseases, surveillance warrants a scientifi c approach. 
To make major inroads into the broader understanding of 
AIV ecology, epidemiology, and evolution, as well as risks 
associated with HPAIV, an integrated sampling strategy 
with clearly defi ned aims and appropriate methods is re-
quired. The fi nancial and logistical constraints of covering 
vast spatial and temporal scales call for concerted efforts 
among our combined virologic, ecologic, and genetic ex-
pertise.  
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